Jintian Pharmaceutical Group Limited provided earnings guidance for the six months ended June 30, 2014. For the six months, the company expects to record a substantial increase in its consolidated net profit for the six months ended 30 June 2014 as compared to that for the corresponding period in 2013, which is mainly attributable to a substantial growth in both the retail and distribution businesses.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 HKD | -4.88% |
|
-2.50% | -21.21% |
Jun. 13 | Universal Health International to Raise Over HK$10.0 Million via Share Subscriptions | MT |
Feb. 28 | Universal Health International Group's Fiscal H1 Loss Narrows | MT |
1st Jan change | Capi. | |
---|---|---|
-21.21% | 7.01M | |
+30.23% | 78.37B | |
+3.26% | 25.35B | |
+14.70% | 8.8B | |
+8.31% | 8.37B | |
-26.58% | 7.34B | |
+16.30% | 5.28B | |
+1.03% | 4.14B | |
-10.14% | 3.78B | |
-4.86% | 3.5B |
- Stock Market
- Equities
- 2211 Stock
- News Universal Health International Group Holding Limited
- Jintian Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2014